ARTICLE | Clinical News
GMI-1271: Phase I started
December 22, 2014 8:00 AM UTC
GlycoMimetics said the University of Michigan began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate single ascending doses of IV GMI-1271 in about 12 healthy adults. ...